Stocklytics Platform
Asset logo for symbol VOR
Vor Biopharma
VOR51
$0.17arrow_drop_down5.62%-$0.01
Penny Stock
Asset logo for symbol VOR
VOR51

$0.17

arrow_drop_down5.62%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Vor Biopharma (VOR) Stocklytics Forecast

Vor Biopharma Inc. (VOR) is a biopharmaceutical company that focuses on developing novel therapies for cancer treatment. The company is dedicated to utilizing its expertise in the field of hematopoietic stem cell transplantation (HSCT) to address the limitations of current treatment options. With a strong pipeline of potential therapies, Vor Biopharma is poised to make a significant impact in the field of oncology.
The stock price of Vor Biopharma Inc. (VOR) has been subject to much speculation and interest from investors. While it is difficult to predict the exact stock price movement, analysts and AI models have provided some insights into the potential future performance of VOR. According to AI price prediction models and machine learning algorithms, the stock is expected to experience steady growth in the coming years. These predictions are based on factors such as the company's pipeline, market trends, and historical data.
add Vor Biopharma to watchlist

Keep an eye on Vor Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Vor Biopharma (VOR) stock?

Analysts have set a target price of $14.84 for Vor Biopharma (VOR), based on forecasts from 29 analysts. The predicted price range extends from a high of $22 to a low of $10. This represents a potential increase of up to 12.26K% and a decrease of 5.52K% from the current price of $0.18. These forecasts are as of 2022 Jul 26.
help

What are the analyst ratings for Vor Biopharma (VOR) stock?

The analyst ratings for Vor Biopharma (VOR) are distributed as follows: 3 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 5 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Vor Biopharma.
help

What is the AI price prediction for Vor Biopharma (VOR) stock?

At present, there is no AI or machine-learning-based price prediction available for Vor Biopharma (VOR) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level